8-K
Current Report
Retension Pharmaceuticals, Inc. Filed Acc 0001213900-26-109024
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading ea0308462-8k_retension.htm…